Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11-Mutated Juvenile Myelomonocytic Leukemia.

azacitidine - Generic mfg.

Mekinist (trametinib) - Novartis, BeOne Medicines

Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11-Mutated Juvenile Myelomonocytic Leukemia. (PubMed, Pediatr Blood Cancer) - Oct 15, 2026 - No abstract available
Journal • Bone Marrow Transplantation • Chronic Myelomonocytic Leukemia • Hematological Malignancies • Juvenile Myelomonocytic Leukemia • Leukemia • Oncology • Transplantation • PTPN11

http://www.ncbi.nlm.nih.gov/pubmed/42873069

Atsushi Manabe; Daichi Sajiki; Hideki Muramatsu; Hisato Segoe; Jutaro Abe; Kazumi Oura; Risa Nakashima; Shinsuke Hirabayashi; Yukayo Terashita; Yuko Cho

Oct 15, 2026